BioCentury

1:00 AM GMT, Oct 5, 2012
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical News

Ablynx gains on Phase II RA data

Ablynx N.V. (Euronext:ABLX) gained EUR 0.94 (18%) to EUR 5.78 on Thursday after reporting interim Phase II data of IV

Read the full 201 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.